EVOLUTION AT MERCK - INVENTING FOR LIFE

MK-8591: UNIQUE PHARMACOLOGY ENABLING POTENTIAL LONG DURATION THERAPY Long-Duration Oral & Implantable Monthly Implantable Continue to simplify HIV care Daily Oral Weekly Elimination Radical simplification Maximize simplicity, of HIV care potency and tolerability Free patients from daily dosing Aspiring to cure Daily dosing for antiretroviral suppression ↓↓Dosing frequency 11 Adherence Sustained viral response or cure Potential to reduce risk of HIV infection ↓↓↓Dosing frequency 111 Adherence PREVENTION [PrEP] TREATMENT CURE MERCK Dr. Roy Baynes | INVENTING FOR LIFE 68

View entire presentation